Barbui, T., Vannucchi, A. M., Alvarez-Larran, A., Iurlo, A., Masciulli, A., Carobbio, A., . . . Rambaldi, A. (2021). High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia.
Dyfyniad Arddull ChicagoBarbui, Tiziano, et al. "High Mortality Rate in COVID-19 Patients With Myeloproliferative Neoplasms After Abrupt Withdrawal of Ruxolitinib." Leukemia 2021.
Dyfyniad MLABarbui, Tiziano, et al. "High Mortality Rate in COVID-19 Patients With Myeloproliferative Neoplasms After Abrupt Withdrawal of Ruxolitinib." Leukemia 2021.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.